Centogene N.V. (CNTG)
0.33
0.01 (1.54%)
At close: Jan 16, 2025, 9:00 PM
1.54% (1D)
| Bid | n/a |
| Market Cap | 9.43M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 0 |
| EPS (ttm) | -1.39 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 7,229,138 |
| Avg. Volume (20D) | 220,749 |
| Open | 0.43 |
| Previous Close | 0.33 |
| Day's Range | 0.33 - 0.43 |
| 52-Week Range | 0.14 - 1.53 |
| Beta | -0.67 |
About CNTG
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, a data and biological repository, which includes epidemiologic, phenotypic, and heterogen...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Nov 7, 2019
Employees 384
Stock Exchange NASDAQ
Ticker Symbol CNTG
Website https://www.centogene.com
7 months ago
+2.76%
Centogene shares are trading lower. The company an...
Unlock content with
Pro Subscription
9 months ago
Centogene shares are trading higher after the company signed a Memorandum of Understanding with C-Path for collaboration in lysosomal disease research and drug development.